ReviewCancers2025
Novel Strategy to Prevent Cancer Metastasis with Metastasis-Regulating miRNAs Found in Extracellular Vesicles Secreted from Stemness-High Cells.
Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Preventing metastasis and recurrence after cancer treatment remains a challenge. Extracellular vesicles (EVs) have long garnered attention as tools for vaccination. To develop high-performance vaccines, there has been an ongoing search for high-performance miRNAs and high-performance EVs as resources. In recent years, stemness-high cells have been reported to represent valuable resources for EVs, offering a level of performance not previously achieved. A differential miRNA analysis was performed between metastasis-suppressive EVs and metastasis-promoting EVs to predict miRNAs specific to metastasis regulation. These newly identified miRNAs were expected to show good performance in metastasis suppression. It is noticeable that these miRNAs seem to be categorized differently from the cancer-associated miRNAs that have been extensively studied to date. In order to further develop vaccine therapy, it is widely recognized that continuing to explore methods for further enhancing the metastasis-suppressive potential of EVs and mRNAs is a fundamental and urgent task. Significant progress has been made through the discovery of stemness-high cells as new EV resources and the results of miRNA exploration focused on metastasis regulation. This review aims to address current challenges by presenting relevant, up-to-date information and providing insights that may lead to new discoveries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.